Literature DB >> 23824832

9p partial monosomy and disorders of sex development: review and postulation of a pathogenetic mechanism.

Shane C Quinonez1, John M Park, Raja Rabah, Kailey M Owens, Beverly M Yashar, Thomas W Glover, Catherine E Keegan.   

Abstract

Deletion of the distal segment of 9p causes a syndrome comprising trigonocephaly, minor anomalies, and intellectual disability. Patients with this condition also frequently present with genitourinary abnormalities including cryptorchidism, hypospadias, ambiguous genitalia, or 46,XY testicular dysgenesis. The region responsible for the gonadal dysgenesis has been localized to 9p24.3 with the likely responsible gene identified as DMRT1. Similar to patients with other molecular causes of 46,XY gonadal dysgenesis, patients with partial del 9p have an increased risk of gonadoblastoma. We present two patients with 46,XY gonadal dysgenesis due to partial 9p monosomy. Both patients were also diagnosed with gonadoblastoma following gonadectomy at an early age. Chromosomal microarray analyses refined the cytogenetic abnormalities and allowed potential genotype-phenotype relationships to be determined. We also review the literature as it pertains to partial 9p monosomy, genital abnormalities and gonadoblastoma and note that a large percentage of affected patients present with two copy number variations. We propose that a two-hit mechanism may be involved in the incomplete penetrance and variable expressivity of partial 9p monosomy and an abnormal genital phenotype. The significant percentage of gonadoblastoma in patients with 46,XY complete gonadal dysgenesis due to partial 9p monosomy also continues to support the necessity of gonadectomy in this patient population.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  9p partial monosomy; disorders of sexual development; distal monosomy 9p; gonadoblastoma

Mesh:

Year:  2013        PMID: 23824832     DOI: 10.1002/ajmg.a.36018

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

Review 1.  DMRT1: An Ancient Sexual Regulator Required for Human Gonadogenesis.

Authors:  David Zarkower; Mark W Murphy
Journal:  Sex Dev       Date:  2021-09-01       Impact factor: 1.824

Review 2.  Male Hypogonadism and Disorders of Sex Development.

Authors:  Romina P Grinspon; Ignacio Bergadá; Rodolfo A Rey
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-15       Impact factor: 5.555

3.  EARLY-ONSET GONADOBLASTOMA IN A 13-MONTH-OLD INFANT WITH 46,XY COMPLETE GONADAL DYSGENESIS IDENTIFIED WITH PRENATAL TESTING: A CASE OF CHROMOSOME 9p DELETION.

Authors:  Meghan E Fredette; Katelyn Cusmano; Chanika Phornphutkul; Jennifer Schwab; Anthony Caldamone; Lisa Swartz Topor
Journal:  AACE Clin Case Rep       Date:  2019-08-14

4.  Extensive clinical, hormonal and genetic screening in a large consecutive series of 46,XY neonates and infants with atypical sexual development.

Authors:  Dorien Baetens; Wilhelm Mladenov; Barbara Delle Chiaie; Björn Menten; An Desloovere; Violeta Iotova; Bert Callewaert; Erik Van Laecke; Piet Hoebeke; Elfride De Baere; Martine Cools
Journal:  Orphanet J Rare Dis       Date:  2014-12-14       Impact factor: 4.123

5.  From karyotypes to precision genomics in 9p deletion and duplication syndromes.

Authors:  Eleanor I Sams; Jeffrey K Ng; Victoria Tate; Ying-Chen Claire Hou; Yang Cao; Lucinda Antonacci-Fulton; Khadija Belhassan; Julie Neidich; Robi D Mitra; F Sessions Cole; Patricia Dickson; Jeffrey Milbrandt; Tychele N Turner
Journal:  HGG Adv       Date:  2021-12-24

6.  Chromosome 9p terminal deletion in nine Egyptian patients and narrowing of the critical region for trigonocephaly.

Authors:  Amal M Mohamed; Alaa K Kamel; Maha M Eid; Ola M Eid; Mona Mekkawy; Shymaa H Hussein; Maha S Zaki; Samira Esmail; Hanan H Afifi; Ghada Y El-Kamah; Ghada A Otaify; Heba Ahmed El-Awady; Aya Elaidy; Mahmoud Y Essa; Mona El-Ruby; Engy A Ashaat; Saida A Hammad; Inas Mazen; Ghada M H Abdel-Salam; Mona Aglan; Samia Temtamy
Journal:  Mol Genet Genomic Med       Date:  2021-10-05       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.